Breast Cancer Mortality In Brazil: Correlation With Human Development Index
Background: Mortality from breast cancer decreased in high-income countries, while countries with middle and low incomes as Brazil still has upward trend. However, large geographical variations among the federal units are observed in the country. The aim of the study was to evaluate the trend of specific mortality from breast cancer in women over 20 years old years among different states of Brazil from 1996 to 2012.
Methods and Findings: Ecological study, using linear regression model for temporal analysis of specific mortality coefficient from malignant neoplasm of breast. We also checked the degree of its correlation with the HDI for the states of Brazil during the stated period. There was an increase in the specific mortality rate for malignant neoplasm of the breast in order of 33%, with range from 23.2 to 30.8 / 100,000 inhabitants. The states with the highest human development HDI in 2010, showed the largest specific mortality rates of breast cancer.
Conclusion: Taking the trends of mortality from cancer an important role, this study confirms the need for improvements in mammography coverage, following radiological lesions suspected and access to appropriate therapy.
2. Jemal A, Center MM, DeSantis C, Ward EM. Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol. 2010 Aug;19(8):1893–907.
3. Bosetti C, Malvezzi M, Chatenoud L, Negri E, Levi F, La Vecchia C. Trends in cancer mortality in the Americas, 1970-2000. Ann Oncol Off J Eur Soc Med Oncol ESMO. 2005 Mar;16(3):489–511.
4. Porter PL. Global trends in breast cancer incidence and mortality. Salud Pública México. 2009;51 Suppl 2:s141–6.
5. Tiezzi DG. Epidemiologia do câncer de mama. Rev Bras Ginecol e Obstetrícia. 2009 May;31(5):213–5.
6. Instituto Nacional de Câncer José Alencar Gomes da Silva (Brasil). Estimativa 2014: Incidência de Câncer no Brasil. Rio de Janeiro (RJ): INCA; 2014. 214 p.
7. Parkin DM, Bray FI, Devesa SS. Cancer burden in the year 2000. The global picture. Eur J Cancer Oxf Engl 1990. 2001 Oct;37 Suppl 8:S4–66.
8. Ministério da Saúde (BR), Departamento de Informação e Informática do SUS, Sistema de Informações sobre Mortalidade (SIM). Atlas de mortalidade por câncer, 2007-2011 [Internet]. Brasília (DF): Ministério da Saúde; 2013 [cited 2014 Jul 14]. Available from: http://mortalidade.inca.gov.br/Mortalidade/prepararModelo01.action
9. Kohatsu EA, Barbieri AR, Hortale VA. Exames de mamografia em Mato Grosso do Sul: análise da cobertura como componente de equidade. Rev Adm Pública. 2009 Jun;43(3):563–77.
10. McLaughlin JM, Anderson RT, Ferketich AK, Seiber EE, Balkrishnan R, Paskett ED. Effect on survival of longer intervals between confirmed diagnosis and treatment initiation among low-income women with breast cancer. J Clin Oncol Off J Am Soc Clin Oncol. 2012 Dec 20;30(36):4493–500.
11. Cancer control: Early detection. Genebra (Suíça): World Health Organization; 2007. 50 p.
12. Ministério da Saúde (BR). Secretaria de Gestão Estratégica e Participativa. Departamento de Articulação Interfederativa. aderno de Diretrizes, Objetivos, Metas e Indicadores: 2013-2015. 2nd ed. Brasília (DF): Ministério da Saúde; 2014. 154 p.
13. Weissman JS, Schneider EC. Social disparities in cancer: lessons from a multidisciplinary workshop. Cancer Causes Control CCC. 2005 Feb;16(1):71–4.
14. Kiadaliri AA. Social disparity in breast and ovarian cancer incidence in Iran, 2003-2009: a time trend province-level study. J Breast Cancer. 2013 Dec;16(4):372–7.
15. Programa das Nações Unidas para o Desenvolvimento. Valores e Desenvolvimento Humano 2010. Brasília (DF): PNUD; 2010.
16. Bray F, Jemal A, Grey N, Ferlay J, Forman D. Global cancer transitions according to the Human Development Index (2008–2030): a population-based study. Lancet Oncol. 2012 Aug;13(8):790–801.
17. Forouzanfar MH, Foreman KJ, Delossantos AM, Lozano R, Lopez AD, Murray CJL, et al. Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. The Lancet. 2011 Oct;378(9801):1461–84.
18. Youlden DR, Cramb SM, Dunn NAM, Muller JM, Pyke CM, Baade PD. The descriptive epidemiology of female breast cancer: an international comparison of screening, incidence, survival and mortality. Cancer Epidemiol. 2012 Jun;36(3):237–48.
19. Azevedo e Silva G, Bustamante-Teixeira MT, Aquino EML, Tomazelli JG, dos-Santos-Silva I, Azevedo e Silva G, et al. Acesso à detecção precoce do câncer de mama no Sistema Único de Saúde: uma análise a partir dos dados do Sistema de Informações em Saúde. Cad Saúde Pública. 2014 Jul;30(7):1537–50.
20. Zapponi ALB, Melo ECP. Distribuição da mortalidade por câncer de mama e de colo de útero segundo regiões brasileiras. Rev Enferm UERJ. 2010 Dec;18(4):628–31.
21. Girianelli VR, Gamarra CJ, Azevedo e Silva G, Girianelli VR, Gamarra CJ, Azevedo e Silva G. Os grandes contrastes na mortalidade por câncer do colo uterino e de mama no Brasil. Rev Saúde Pública. 2014 Jun;48(3):459–67.
22. Lima C, Rangel MR, Macedo-Lima M, da Silva A. Time trends in breast cancer incidence and mortality in a mid-sized northeastern Brazilian city. BMC Public Health. 2012;12(1):883.
23. Rodrigues AD, Bustamante-Teixeira MT. Mortalidade por câncer de mama e câncer de colo do útero em município de porte médio da Região Sudeste do Brasil, 1980-2006. Cad Saúde Pública. 2011 Feb;27(2):241–8.
24. Melo WA de, Zurita RCM, Carvalho MD de B. Fatores associados na mortalidade por cancer de mama no Noroeste Paranaense [Internet]. 1o Congresso Virtual Brasileiro - Gestão, Educação e Promoção da Saúde; 2012. Available from: http://www.convibra.com.br/dwp.asp?id=4292&ev=24
25. Kobayashi S. What caused the decline in breast cancer mortality in the United Kingdom? Breast Cancer Tokyo Jpn. 2004;11(2):156–9.
26. Gatta G, Trama A, Capocaccia R. Variations in cancer survival and patterns of care across Europe: roles of wealth and health-care organization. J Natl Cancer Inst Monogr. 2013;2013(46):79–87.
27. Schrijvers CT, Mackenbach JP. Cancer patient survival by socioeconomic status in seven countries: a review for six common cancer sites [corrected]. J Epidemiol Community Health. 1994 Oct;48(5):441–6.
28. Coleman MP. Opinion: why the variation in breast cancer survival in Europe? Breast Cancer Res. 1999;1(1):22–6.
29. Montella M, Crispo A, D’Aiuto G. Inequalities in the healthcare system and breast cancer survival. Int J Cancer. 2004 Mar 10;109(1):153–4.
30. Bouchardy C, Verkooijen HM, Fioretta G. Social class is an important and independent prognostic factor of breast cancer mortality. Int J Cancer J Int Cancer. 2006 Sep 1;119(5):1145–51.
31. Thomson C, Hole D, Twelves C, Brewster D, Black R. Prognostic factors in women with breast cancer: distribution by socioeconomic status and effect on differences in survival. J Epidemiol Community Health. 2001 May;55(5):308–15.
32. Elstad JI, Torstensrud R, Lyngstad TH, Kravdal O. Trends in educational inequalities in mortality, seven types of cancers, Norway 1971-2002. Eur J Public Health. 2012 Dec 1;22(6):771–6.
33. DeSantis C, Siegel R, Bandi P, Jemal A. Breast cancer statistics, 2011. CA Cancer J Clin. 2011 Nov 1;61(6):408–18.
34. Hunter CP. Epidemiology, stage at diagnosis, and tumor biology of breast carcinoma in multiracial and multiethnic populations. Cancer. 2000 Mar 1;88(5 Suppl):1193–202.
35. Herndon JE, Kornblith AB, Holland JC, Paskett ED. Effect of socioeconomic status as measured by education level on survival in breast cancer clinical trials. Psychooncology. 2013 Feb;22(2):315–23.
36. Schneider IJC, d’ Orsi E. Sobrevida em cinco anos e fatores prognósticos em mulheres com câncer de mama em Santa Catarina, Brasil. Cad Saúde Pública. 2009 Jun;25(6):1285–96.
Copyright policies & self-archiving
We are a RoMEO green journal.
Author's Pre-print: author can archive pre-print (ie pre-refereeing)
Author's Post-print: author can archive post-print (ie final draft post-refereeing)
Publisher's Version/PDF: author can archive publisher's version/PDF
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access and Benefits of Publishing Open Access).
This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.
Articles are published Under License of Creative Commons Attribution 4.0 License ©